Anika Therapeutics (ANIK) Inventory Average (2011 - 2026)

Anika Therapeutics (ANIK) has 16 years of Inventory Average data on file, last reported at $20.8 million in Q1 2026.

• On a quarterly basis, Inventory Average fell 7.8% year-over-year to $20.8 million in Q1 2026; TTM through Mar 2026 was $20.8 million, a 7.8% decrease from a year earlier, with the FY2025 full-year figure at $21.3 million, down 11.69% from the prior year.
• Inventory Average for Q1 2026 stood at $20.8 million, up from $17.5 million in the prior quarter.
• Over the last five years, Inventory Average for ANIK reached as high as $50.4 million in Q2 2024 and fell as low as $16.6 million in Q3 2025.
• Historically, Inventory Average has averaged $33.3 million across 5 years, with a median of $35.6 million in 2022.
• Across the five-year window, Inventory Average advanced 20.2% in 2024 and plunged 63.55% in 2025, its largest moves.
• Year by year, Inventory Average stood at $38.5 million in 2022, then fell by 11.49% to $34.1 million in 2023, then declined by 6.92% to $31.7 million in 2024, then tumbled by 44.72% to $17.5 million in 2025, then climbed by 18.69% to $20.8 million in 2026.
• Per Business Quant data, the three most recent Inventory Average figures were $20.8 million in Q1 2026, $17.5 million in Q4 2025, and $16.6 million in Q3 2025.